Envveno Medical Corp Stock Analysis

NVNO Stock  USD 5.76  0.19  3.19%   
enVVeno Medical Corp is undervalued with Real Value of 9.5 and Target Price of 20.4. The main objective of EnVVeno Medical stock analysis is to determine its intrinsic value, which is an estimate of what enVVeno Medical Corp is worth, separate from its market price. There are two main types of EnVVeno Medical's stock analysis: fundamental analysis and technical analysis.
The EnVVeno Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. EnVVeno Medical is usually not traded on Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. EnVVeno Stock trading window is adjusted to America/New York timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

EnVVeno Stock Analysis Notes

About 27.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. enVVeno Medical Corp recorded a loss per share of 1.65. The entity last dividend was issued on the 30th of November 2020. The firm had 1:25 split on the 30th of November 2020. enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. Envveno Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 24 people. To find out more about enVVeno Medical Corp contact Robert Berman at 949 261 2900 or learn more at https://www.envveno.com.

enVVeno Medical Corp Investment Alerts

enVVeno Medical Corp had very high historical volatility over the last 90 days
Net Loss for the year was (23.52 M) with profit before overhead, payroll, taxes, and interest of 0.
enVVeno Medical Corp currently holds about 37.48 M in cash with (18.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96.
enVVeno Medical Corp has a poor financial position based on the latest SEC disclosures
Latest headline from simplywall.st: Heres Why Were Not Too Worried About enVVeno Medicals Cash Burn Situation

enVVeno Medical Corp Upcoming and Recent Events

Earnings reports are used by EnVVeno Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
25th of January 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
25th of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

EnVVeno Largest EPS Surprises

Earnings surprises can significantly impact EnVVeno Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-08-05
2019-06-30-0.11-0.13-0.0218 
2021-08-11
2021-06-30-0.34-0.280.0617 
2021-11-12
2021-09-30-0.34-0.260.0823 
View All Earnings Estimates

EnVVeno Medical Environmental, Social, and Governance (ESG) Scores

EnVVeno Medical's ESG score is a quantitative measure that evaluates EnVVeno Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of EnVVeno Medical's operations that may have significant financial implications and affect EnVVeno Medical's stock price as well as guide investors towards more socially responsible investments.

EnVVeno Medical Thematic Classifications

In addition to having EnVVeno Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Health Management Idea
Health Management
Healthcare providers, hospitals

EnVVeno Stock Institutional Investors

Shares
Blackrock Inc2024-03-31
37.5 K
Northern Trust Corp2024-03-31
35.1 K
Janney Montgomery Scott Llc2024-03-31
34.1 K
Laird Norton Tyee Trust Co2024-03-31
33 K
Fermata Advisors, Llc2024-06-30
30.9 K
State Street Corporation2024-03-31
24.6 K
Squarepoint Ops Llc2024-03-31
22.4 K
Quadrature Capital Llp2024-03-31
18.9 K
Dimensional Fund Advisors, Inc.2024-03-31
16.4 K
Kingdon Capital Management Llc2024-03-31
653.9 K
Perceptive Advisors Llc2024-03-31
623.3 K
Note, although EnVVeno Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

EnVVeno Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 79.31 M.

EnVVeno Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.48)(0.51)
Return On Capital Employed(0.53)(0.51)
Return On Assets(0.48)(0.51)
Return On Equity(0.51)(0.53)

Management Efficiency

enVVeno Medical Corp has return on total asset (ROA) of (0.3675) % which means that it has lost $0.3675 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5782) %, meaning that it created substantial loss on money invested by shareholders. EnVVeno Medical's management efficiency ratios could be used to measure how well EnVVeno Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of July 2024, Return On Tangible Assets is likely to drop to -0.51. In addition to that, Return On Capital Employed is likely to grow to -0.51. At this time, EnVVeno Medical's Total Assets are very stable compared to the past year. As of the 18th of July 2024, Non Current Assets Total is likely to grow to about 1.8 M, while Non Currrent Assets Other are likely to drop about 29.4 K.
Last ReportedProjected for Next Year
Book Value Per Share 3.76  3.94 
Tangible Book Value Per Share 3.76  3.94 
Enterprise Value Over EBITDA(2.47)(2.59)
Price Book Value Ratio 1.37  1.44 
Enterprise Value Multiple(2.47)(2.59)
Price Fair Value 1.37  1.44 
Enterprise Value61 M64.1 M
The analysis of EnVVeno Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze EnVVeno Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of EnVVeno Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.248
Return On Assets
(0.37)
Return On Equity
(0.58)

Technical Drivers

As of the 18th of July 2024, EnVVeno Medical shows the risk adjusted performance of 0.0674, and Semi Deviation of 2.05. In respect to fundamental indicators, the technical analysis model provides you with a way to check existing technical drivers of EnVVeno Medical, as well as the relationship between them.

enVVeno Medical Corp Price Movement Analysis

Execute Study
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. EnVVeno Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for enVVeno Medical Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

enVVeno Medical Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EnVVeno Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on EnVVeno Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EnVVeno Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

EnVVeno Medical Outstanding Bonds

EnVVeno Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. enVVeno Medical Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EnVVeno bonds can be classified according to their maturity, which is the date when enVVeno Medical Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

EnVVeno Medical Predictive Daily Indicators

EnVVeno Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EnVVeno Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

EnVVeno Medical Corporate Filings

10th of May 2024
Other Reports
ViewVerify
10Q
8th of May 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
24th of April 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
15th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
6th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10K
29th of February 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
13A
23rd of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify

EnVVeno Medical Forecast Models

EnVVeno Medical's time-series forecasting models are one of many EnVVeno Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EnVVeno Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About EnVVeno Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how EnVVeno Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling EnVVeno shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as EnVVeno Medical. By using and applying EnVVeno Stock analysis, traders can create a robust methodology for identifying EnVVeno entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(280.68)(266.64)
Operating Profit Margin(282.51)(268.39)
Net Loss(280.68)(266.64)
Gross Profit Margin 0.01  0.01 

Current EnVVeno Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. EnVVeno analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. EnVVeno analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
20.4Strong Buy1Odds
enVVeno Medical Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most EnVVeno analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand EnVVeno stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of enVVeno Medical Corp, talking to its executives and customers, or listening to EnVVeno conference calls.
EnVVeno Analyst Advice Details

EnVVeno Stock Analysis Indicators

enVVeno Medical Corp stock analysis indicators help investors evaluate how EnVVeno Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading EnVVeno Medical shares will generate the highest return on investment. By understating and applying EnVVeno Medical stock analysis, traders can identify EnVVeno Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow4.6 M
Common Stock Shares Outstanding12.3 M
Total Stockholder Equity46.2 M
Property Plant And Equipment Net1.7 M
Cash And Short Term Investments46.4 M
Cash3.6 M
Accounts Payable427 K
Net Debt-2.2 M
50 Day M A5.0766
Total Current Liabilities1.4 M
Other Operating Expenses25.2 M
Non Current Assets Total1.7 M
Non Currrent Assets Other31 K
Stock Based Compensation5.2 M

Additional Information and Resources on Investing in EnVVeno Stock

When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.65)
Return On Assets
(0.37)
Return On Equity
(0.58)
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.